What a stem cell clinic Chandler visit may include

Bring the facts that help the exam

Gather each drug name, earlier joint reports, and the dates of past care. Add a note about anything that eased or worsened the ache.

Wear loose clothes so the examiner can see and move the sore area. You'll discuss swelling, weakness, sleep, and the daily tasks you miss.

Ask if a physician assistant, nurse practitioner, or doctor will run the exam. A family member can take notes while you answer the exam questions.

Ask what may be used

PRP means blood from your arm prepared with more platelets, which are blood fragments that form clots. The provider returns that prepared blood to your joint through a needle.

Bone marrow aspirate concentrate is marrow drawn through a needle from your pelvis. The clinic spins it, removes some liquid, and places the remaining marrow in your joint.

The marrow still holds many kinds of cells, not one selected cell. Ask what will enter your joint and how the staff guards against infection.

Ask why that choice fits

Your exam and health history help the provider judge each choice. Earlier care and your present limits show what has already failed.

Ask which soreness or movement may improve and when you'll return. Also ask what the provider can't predict and what risks may occur.

Know what to do after the visit

Before leaving, get written directions for movement, medicines, and follow-up care. Find out whom to call if swelling or redness grows worse.

Don't change prescribed medicine until the prescriber agrees. QC Kinetix offers biologic therapies, meaning a licensed provider may place prepared blood or marrow into your joint through a needle after an exam.

Sources

1. The International Society for Cell & Gene Therapy position statement holds that the acronym MSC should mean mesenchymal STROMAL cells and should only be called stem cells where rigorous in vitro and in vivo evidence of stemness exists for that specific preparation.

   Viswanathan S, et al. — Mesenchymal stem versus stromal cells: International Society for Cell & Gene Therapy (ISCT®) Mesenchymal Stromal Cell committee position statement on nomenclature. Cytotherapy, 2019. DOI: 10.1016/j.jcyt.2019.08.002.

2. The 2005 International Society for Cellular Therapy statement that first flagged the problem concluded that plastic-adherent marrow cells do not meet generally accepted criteria for stem cell activity, making the name 'mesenchymal stem cell' scientifically inaccurate and potentially misleading to the lay public.

   Horwitz EM, et al. — Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy, 2005. DOI: 10.1080/14653240500319234.

3. The 2018 AAOS/NIH consensus work group recommended that minimally manipulated mixed cell preparations be called CELL THERAPY rather than stem cell therapy, and that their untested and uncharacterised nature be clearly communicated to patients and the public, because stem cells have properties these preparations do not meet.

   Chu CR, et al. — Optimizing Clinical Use of Biologics in Orthopaedic Surgery: Consensus Recommendations From the 2018 AAOS/NIH U-13 Conference. J Am Acad Orthop Surg, 2019. DOI: 10.5435/JAAOS-D-18-00305.

4. Mesenchymal stromal cells make up only about 0.001 to 0.01 percent of the nucleated cells in bone marrow, so the harvesting and processing technique - aspiration site, syringe size, centrifuge speed and time - materially determines what ends up in the syringe, and no consensus protocol exists.

   Jeyaraman M, et al. — Impact of the Process Variables on the Yield of Mesenchymal Stromal Cells from Bone Marrow Aspirate Concentrate. Bioengineering (Basel), 2022. DOI: 10.3390/bioengineering9020057.